Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



FDA Warns St. Jude of "Non-Conformities" at California Plant

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

On Monday, St. Jude Medical (NYSE: STJ  ) admitted in an SEC filing that it received a warning letter from the U.S. Food and Drug Administration Friday.

According to the filing, in the letter addressed to the company's Implantable Electronic Systems Division, the FDA described "non-conformities with Current Good Manufacturing Practice at the Company's Implantable Electronic Systems Division's Sylmar, California facility," discovered during inspections of the plant conducted between Sept. 25 and Oct. 17 of last year.

In its SEC filing, St. Jude highlighted the fact that the warning "does not impact any of the Company's other manufacturing facilities" and added: "As previously disclosed by management on its third quarter earnings call on October 17, 2012, this warning letter was expected." Furthermore, St. Jude says that it "immediately initiated efforts to address FDA's observations of non-conformity" when they were discovered after these inspections.

St. Jude also says that because no "specific concerns regarding the performance of, or ... need for any field or other action regarding the Riata ST Optim or Durata leads or any other St. Jude Medical product" were stated in the FDA's letter, it plans to "continue manufacturing and shipping product from the Sylmar facility," and "customer orders are not expected to be affected while we work to resolve the FDA's concerns."

St. Jude promised to provide additional detail on any financial impact of the FDA's actions in its end-of-year earnings conference call, scheduled for Jan. 23.

Shares closed the day up 1.5% at $38.85.

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2195357, ~/Articles/ArticleHandler.aspx, 9/30/2016 11:25:47 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,317.06 173.61 0.96%
S&P 500 2,171.24 20.11 0.93%
NASD 5,307.65 38.49 0.73%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/30/2016 11:10 AM
STJ $79.72 Up +0.76 +0.96%
St. Jude Medical CAPS Rating: **